MERCK ENTERS INTO EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH SCIBRUNCH THERAPEUTICS FOR SPR2015, AN INVESTIGATIONAL ORAL KRAS G12D (ON) INHIBITOR (DESIGNED TO BLOCK THE KRAS G12D GENE MUTATION THAT CAUSES TUMOURS TO GROW IN CANCERS LIKE PANCREATIC AND COLORECTAL CANCER)
Meta has again gotten the jump on Apple, writes Mark Gurman. The launch of the Meta VR Glasses elegantly offloads the computing engine, allowing the device to weigh one-sixth as much as the Vision Pro — at one-third of the price.
Read the latest edition of the Power On newsletter:
📷: David Paul Morris/Bloomberg